Clinical Trials Insight: 700041500

Trial Profile

Clinical Trials Insight: 700041500

Phase of Trial: Phase I

Latest Information Update: 12 Feb 2009

At a glance

  • Drugs Anti-CD20 monoclonal antibody (Primary)
  • Indications Lymphoid leukaemia
  • Focus Adverse reactions
  • Sponsors LFB
  • Most Recent Events

    • 12 Feb 2009 New trial record.
    • 10 Feb 2009 Dosing has commenced according to an LFB media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top